Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions. The company operates five clinics under the Levitee Clinics name; and three pharmacies in Alberta under the Levitee Pharmacies name. In addition, it offers electronic-prescriptions in the addiction treatment space under the BlockMD name; and wholesales supplements and superfood under the Earth Circle Organics name. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.
Frequently asked questions
What sector does Levitee Labs Inc (LVTTF) operate in?
Levitee Labs Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Levitee Labs Inc (LVTTF) current stock price?
As of the latest data, Levitee Labs Inc stock price is $0.00, with a previous close of $0.00. Levitee Labs Inc lost -$0.00 in the last trading session, representing a -25.93% loss.
What is Levitee Labs Inc (LVTTF) current market capitalization?
Levitee Labs Inc market cap is approximately 200.84 thousand.
What is Levitee Labs Inc (LVTTF) Earnings Per Share (EPS)?
The trailing EPS is -$0.11.
Does Levitee Labs Inc (LVTTF) pay dividends?
No. Levitee Labs Inc does not pay a dividend.
What is Levitee Labs Inc (LVTTF) beta (volatility) score?
Levitee Labs Inc has a beta of 1.519, suggesting it is more volatile than the market.